Best Cardiovascularrisk Podcasts (2025)

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Alan Brown: Lp(a) – What You Need to Know 31:43

3M ago31:43

31:43

In this podcast, expert clinicians will discuss the role of lipoprotein(a) [Lp(a)] in atherogenesis and emerging therapies that reduce Lp(a). To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/cardiology/20250303/5-lipid-legends-with-your-h…

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. James Underberg: Familial Hypercholesterolemia – Risk Assessment and Treatment 33:25

3M ago33:25

33:25

In this podcast, expert clinicians will assess the latest understanding regarding homozygous and heterozygous familial hypercholesterolemia (FH), risk assessment, and options for management. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalk…

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Peter Toth: PCSK9 Inhibition 36:28

5M ago36:28

36:28

In this podcast, expert clinicians will review the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in reducing low-density lipoprotein cholesterol (LDL-C) and reducing cardiovascular risk. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://h…

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Thomas Dayspring: Perils of Hypertriglyceridemia 34:29

6M ago34:29

34:29

In this podcast, expert clinicians will discuss clinical challenges related to hypertriglyceridemia and its therapies. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/cardiology/20241125/6-lipid-legends-with-your-host-dr-ronald-codario-f…

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Christie Ballantyne: CETP Inhibition 27:27

7M ago27:27

27:27

In this podcast, expert clinicians will discuss the latest evidence regarding the role of cholesteryl ester transfer protein (CETP) inhibitors in the management of patients with dyslipidemia. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtal…

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Michael Davidson: Assessing Cardiovascular Risk 35:37

7M ago35:37

35:37

In this podcast, expert clinicians will discuss the latest recommendations to assess cardiovascular risk, residual risk, and low-density lipoprotein cholesterol (LDL-C) goals for therapy. To claim CE credit after listening to this episode, go to this link and check the "Already listened on another platform?" box: https://healio.com/cme/mededtalks/c…

1
sGC Modulators in HFrEF: MOA, Clinical Evidence, With Drs. IIeana Pina and Javed Butler 15:13

2y ago15:13

15:13

In this podcast, expert clinicians will discuss the mechanism of action of and clinical evidence for the use of soluble guanylate cyclase (sGC) modulators in heart failure with reduced ejection fraction (HFrEF).

1
Updated Guidelines Recommendations for the Management of HFrEF and Worsening HF, With Drs. Ileana Pina and Shelley Zieroth 13:44

2y ago13:44

13:44

In this podcast, expert clinicians will discuss the updated guideline recommendations for the management of heart failure with reduced ejection fraction (HFrEF) and worsening HF.

1
Burden of HFrEF and Worsening HF, With Drs. Ileana Piña and Javed Butler 17:40

2y ago17:40

17:40

In this podcast, expert clinicians will discuss the burden of HFrEF and worsening HF.

1
Case Discussion: ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera 16:43

3y ago16:43

16:43

In this podcast, expert clinicians will discuss evidence-based management of CV risk reduction.

1
Clinical Evidence for Omega-3 Polyunsaturated Fatty Acids for Managing ASCVD Risk With Drs. Peter Toth and Pam Taub 15:46

3y ago15:46

15:46

Clinical Evidence for Omega-3 PUFAs for Managing CV Risk with Drs. Peter Toth and Pam Taub.

1
The Impact of Omega-3 PUFAs on ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera 18:54

3y ago18:54

18:54

The Impact of Omega-3 PUFAs on CV Risk Reduction with Drs. Peter Toth and Amit Khera.

1
The Role of Inflammation in Atherosclerosis With Drs. Peter Toth and Pam Taub 13:55

3y ago13:55

13:55

In this podcast, expert clinicians will discuss the role of inflammation in atherosclerosis.

1
Challenges in Embolic Stroke: Deciding Between Combination Medical and PFO Closure or Medical Management Alone With Drs. Howard Herrmann and John Carroll 18:33

3y ago18:33

18:33

In this podcast, expert clinicians will discuss management selection for embolic stroke with a PFO.By Dr. Howard Herrmann

1
Challenges in Embolic Stroke: Embolic Stroke Treatment With Drs. Howard Herrmann and John Carroll 16:37

3y ago16:37

16:37

In this podcast, expert clinicians will discuss treatment options for embolic stroke due to a PFO.By Dr. Howard Herrmann

1
Challenges in Embolic Stroke: Getting With the Guidelines – PFO Closure and the Use of Medical Therapy With Drs. Howard Herrmann and Scott Kasner 14:18

3y ago14:18

14:18

In this podcast, expert clinicians will discuss the current guidelines for the management of embolic stroke with a PFO.By Dr. Howard Herrmann

1
Challenges in Embolic Stroke: Confronting Challenges in Diagnosis With Drs. Howard Herrmann and Scott Kasner 17:20

3y ago17:20

17:20

In this podcast, expert clinicians will discuss challenges in the diagnosis of embolic stroke with a PFO.By Dr. Howard Herrmann

1
PFO Closure: Procedural Pearls and Important Considerations with Drs. Herrmann, Carroll, and Kasner 14:36

4y ago14:36

14:36

In this podcast, expert clinicians will share procedural pearls for PFO closure and important considerations to optimize patient outcomes.By Dr. Howard Herrmann

1
Managing Patients With Cryptogenic Stroke: Clinical Perspectives, with Drs. Herrmann, Carroll, and Kasner 13:52

4y ago13:52

13:52

In this podcast, expert clinicians will discuss management of patients with cryptogenic stroke as well as strategies for applying new guideline recommendations into practice.By Dr. Howard Herrmann

1
The Relationship Between PFO and Cryptogenic Stroke: Reviewing the Data, with Drs. Herrmann, Carroll, and Kasner 15:28

4y ago15:28

15:28

In this podcast, expert clinicians will discuss the association between patent foramen ovale and stroke and review the current clinical data to support PFO closure.By Dr. Howard Herrmann

1
Diagnosis and Classification of Cryptogenic Stroke and PFO-Associated Stroke, with Drs. Herrmann, Carroll, and Kasner 16:28

4y ago16:28

16:28

In this podcast, expert clinicians will discuss strategies for classification and workup of cryptogenic stroke and PFO-associated stroke.By Dr. Howard Herrmann

1
Recent Cardiovascular Outcomes Trials: Reducing Triglycerides for Further Risk Reduction with Drs. Pamela Morris and Deepak Bhatt 16:25

4y ago16:25

16:25

In this podcast, expert clinicians will discuss latest clinical evidence from cardiovascular outcomes trials and how reducing triglycerides for further reduces risk.By Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA

1
Deep Dive Into Clinical Evidence: Reducing CVD risk through LDL-C reduction with Drs. Pamela Morris and Ann Marie Navar 17:10

4y ago17:10

17:10

In this podcast, expert clinicians will discuss evidence regarding mitigating cardiovascular risk by LDL-C reduction.By Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA

1
Patient Identification for Residual Risk Management: Who’s At Risk? with Drs. Pamela Morris and Martha Gulati 11:58

4y ago11:58

11:58

In this podcast, expert clinicians will discuss secondary prevention and how to identify patients who may benefit from additional treatment to reduce CV risk.By Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA

1
Strategies for Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment: What’s the Risk? with Drs. Pamela Morris and Martha Gulati 15:26

4y ago15:26

15:26

In this podcast, expert clinicians discuss primary prevention as well as strategies for ASCVD risk assessment.By Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA

1
sGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed Butler 14:46

4+ y ago14:46

14:46

In this podcast, expert clinicians will discuss the potential use of sGC modulators in the management of patients with heart failure with reduced ejection fraction (HFrEF).By Dr. Paul Armstrong

1
The Clinical Evidence: Efficacy and Safety of sGC Modulators in Heart Failure With Reduced Ejection Fraction With Drs. Paul Armstrong and Javed Butler 14:54

4+ y ago14:54

14:54

In this podcast, expert clinicians will discuss the safety and efficacy of sGC modulators that was seen in various clinical trials.By Dr. Paul Armstrong

1
sGC Modulators: Unique Mechanism of Action and Rationale for Use in Heart Failure With Drs. Paul Armstrong and Carolyn Lam 11:18

4+ y ago11:18

11:18

In this podcast, expert clinicians will discuss the mechanism of action of sGC modulators and the rationale for its use in patients with heart failure.By Dr. Paul Armstrong

1
Heart Failure Management: Guideline-directed Therapy and Unmet Needs With Drs. Paul Armstrong and Carolyn Lam 14:15

4+ y ago14:15

14:15

In this podcast, expert clinicians will discuss the burden of heart failure in the United States and the potential of new therapies for treating heart failure.By Dr. Paul Armstrong

1
Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Blood Pressure Control and Optimizing Care Coordination and Medication Management ... 10:52

5+ y ago10:52

10:52

In this podcast, Deepak L. Bhatt, MD, and Peter P. Toth, MD, PhD, discuss blood pressure control as well as optimizing care coordination and medication management in the patient with diabetes. Transcript: https://tinyurl.com/yj8zwh69 To earn CME credit, go here: https://cme.healio.com/mededtalks/cardiology/2019/12_december/mededtalks-in-cardiology-…

1
Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Reducing CV Risk in Patients With Diabetes – A Discussion on the Latest Data 13:00

5+ y ago13:00

13:00

In this podcast, Deepak L. Bhatt, MD, and Peter P. Toth, MD, PhD, discuss the latest data on reducing CV risk in patients with diabetes. Transcript: https://tinyurl.com/yeendrms To earn CME Credit, go here: https://cme.healio.com/mededtalks/cardiology/2019/12_december/mededtalks-in-cardiology-reducing-cv-risk-in-patients-with-diabetes-a-discussion-…

1
Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; The Interplay Between T2DM and CV Risk – Implications for Patients 12:31

5+ y ago12:31

12:31

In this podcast, Deepak L. Bhatt, MD, and Peter P. Toth, MD, PhD, discuss the interplay between T2DM and CV risk. Transcript: https://tinyurl.com/yh9kt3al To earn CME credits, go here: https://cme.healio.com/mededtalks/cardiology/2019/12_december/mededtalks-in-cardiology-the-interplay-between-t2dm-and-cv-risk-implications-for-patients…

1
MedEd Talks in Cardiology - Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists 1:04

5+ y ago1:04

1:04

By Deepak Bhatt, MD

Podcasts Worth a Listen

Cardiovascularrisk Podcasts

Podcasts Worth a Listen

1
MedEdTalks - Cardiology

Vindico Medical Education

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Alan Brown: Lp(a) – What You Need to Know 31:43

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. James Underberg: Familial Hypercholesterolemia – Risk Assessment and Treatment 33:25

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Peter Toth: PCSK9 Inhibition 36:28

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Thomas Dayspring: Perils of Hypertriglyceridemia 34:29

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Christie Ballantyne: CETP Inhibition 27:27

1
Lipid Legends With Your Host Dr. Ronald Codario, Featuring Dr. Michael Davidson: Assessing Cardiovascular Risk 35:37

1
sGC Modulators in HFrEF: MOA, Clinical Evidence, With Drs. IIeana Pina and Javed Butler 15:13

1
Updated Guidelines Recommendations for the Management of HFrEF and Worsening HF, With Drs. Ileana Pina and Shelley Zieroth 13:44

1
Burden of HFrEF and Worsening HF, With Drs. Ileana Piña and Javed Butler 17:40

1
Case Discussion: ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera 16:43

1
Clinical Evidence for Omega-3 Polyunsaturated Fatty Acids for Managing ASCVD Risk With Drs. Peter Toth and Pam Taub 15:46

1
The Impact of Omega-3 PUFAs on ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera 18:54

1
The Role of Inflammation in Atherosclerosis With Drs. Peter Toth and Pam Taub 13:55

1
Challenges in Embolic Stroke: Deciding Between Combination Medical and PFO Closure or Medical Management Alone With Drs. Howard Herrmann and John Carroll 18:33

1
Challenges in Embolic Stroke: Embolic Stroke Treatment With Drs. Howard Herrmann and John Carroll 16:37

1
Challenges in Embolic Stroke: Getting With the Guidelines – PFO Closure and the Use of Medical Therapy With Drs. Howard Herrmann and Scott Kasner 14:18

1
Challenges in Embolic Stroke: Confronting Challenges in Diagnosis With Drs. Howard Herrmann and Scott Kasner 17:20

1
PFO Closure: Procedural Pearls and Important Considerations with Drs. Herrmann, Carroll, and Kasner 14:36

1
Managing Patients With Cryptogenic Stroke: Clinical Perspectives, with Drs. Herrmann, Carroll, and Kasner 13:52

1
The Relationship Between PFO and Cryptogenic Stroke: Reviewing the Data, with Drs. Herrmann, Carroll, and Kasner 15:28

1
Diagnosis and Classification of Cryptogenic Stroke and PFO-Associated Stroke, with Drs. Herrmann, Carroll, and Kasner 16:28

1
Recent Cardiovascular Outcomes Trials: Reducing Triglycerides for Further Risk Reduction with Drs. Pamela Morris and Deepak Bhatt 16:25

1
Deep Dive Into Clinical Evidence: Reducing CVD risk through LDL-C reduction with Drs. Pamela Morris and Ann Marie Navar 17:10

1
Patient Identification for Residual Risk Management: Who’s At Risk? with Drs. Pamela Morris and Martha Gulati 11:58

1
Strategies for Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment: What’s the Risk? with Drs. Pamela Morris and Martha Gulati 15:26

1
sGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed Butler 14:46

1
The Clinical Evidence: Efficacy and Safety of sGC Modulators in Heart Failure With Reduced Ejection Fraction With Drs. Paul Armstrong and Javed Butler 14:54

1
sGC Modulators: Unique Mechanism of Action and Rationale for Use in Heart Failure With Drs. Paul Armstrong and Carolyn Lam 11:18

1
Heart Failure Management: Guideline-directed Therapy and Unmet Needs With Drs. Paul Armstrong and Carolyn Lam 14:15

1
Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Blood Pressure Control and Optimizing Care Coordination and Medication Management ... 10:52

1
Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; Reducing CV Risk in Patients With Diabetes – A Discussion on the Latest Data 13:00

1
Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists; The Interplay Between T2DM and CV Risk – Implications for Patients 12:31

1
MedEd Talks in Cardiology - Cardiovascular Risk Reduction in Patients with Diabetes: Coordinating Efforts Between Cardiologists and Endocrinologists 1:04